• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconGLP-1s

GLP-1s

Jeff La Marca
Health
The Medicare GLP-1 discount is here, so why are some sick people excluded?
By Jackie Fortiér and KFF Health NewsAugust 25, 2026
t
Health
‘Game-changer’ GLP-1s could fix America’s obesity crisis—but 2 inequalities stand in the way
By Nick LichtenbergAugust 20, 2026
glp
Commentary
The hidden risk of GLP-1 drugs
By Jessica Starr and Emily SteinAugust 14, 2026
Brian Moynihan, chief executive officer of Bank of America
Success
Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great impact on employees,’ CEO says
By Emma BurleighAugust 7, 2026
glp
Commentary
The GLP-1 paradox: too expensive to cover, too effective to cut
By Bryan Sivak and Elina OnitskanskyJuly 23, 2026
Sean McClain wears a lab coat
Startups & Venture
Eli Lilly just placed a $40 million bet on the next injectable boom
By Lily Mae LazarusJuly 1, 2026
A pedestrian walks past a Gucci luxury fashion store at a shopping district on June 24, 2026, in Shenzhen, Guangdong Province, China.
Retail
Rich consumers taking GLP-1s are rebuying their wardrobes and eating smaller, fancier dishes—it’s a factor saving the luxury sector right now
By Eleanor PringleJune 25, 2026
How ‘Ozempic face’ is pushing Gen X, already the biggest Botox and filler consumers, to the facelift table a decade early
Health
How ‘Ozempic face’ is pushing Gen X, already the biggest Botox and filler consumers, to the facelift table a decade early
By Mia OsmonbekovJune 24, 2026
UPS workers process boxes in a sorting facility.
North America
UPS is shelling out nearly $50 million on temperature-controlled facilities to meet the booming demand for GLP-1 deliveries
By Sasha RogelbergJune 23, 2026
Tenzin Seldon is the founder and managing partner of Pulse Fund,
Commentary
Tenzin Seldon: The GLP-1 boom is the biggest climate story no one is pricing in
By Tenzin SeldonJune 21, 2026
Alamar team rings the closing Nasdaq bell while confetti falls.
Banking
From drought to demand: Biotech IPOs roar back with Kailera and Alamar
By Lily Mae LazarusApril 18, 2026
glp-wonderful
Success
Ozempic mania has even Olive Garden and The Cheesecake Factory cutting back on portion sizes
By Dee-Ann Durbin and The Associated PressMarch 12, 2026
addiction
Health
GLP-1s cure hunger for a lot more than food, my study of 600,000 people suggests
By Ziyad Al-Aly and The ConversationMarch 6, 2026
shopper
Banking
Meat snacks have emerged as the clear winner in America’s seismic GLP-1 consumption shift, while popcorn is down
By Nick LichtenbergFebruary 10, 2026
tara comonte
Commentary
Weight Watchers CEO: what the GLP-1 Super Bowl ads are missing
By Tara ComonteFebruary 9, 2026
1
  • 1
  • 2
  • 3
3
Most Popular
Investing
New LA Angels owner Stan Kroenke is quietly America's largest private landowner, boasting 2.7 million acres and besting Bill Gates and Jeff Bezosplaceholder alt text
By Sasha RogelbergSeptember 2, 2026
Success
The heiress of $10 billion Perdue Farms and the $12 billion Sheraton Hotels empire wore hand-me-downs, still rides the subway, and flies economyplaceholder alt text
By Emma BurleighAugust 30, 2026
Success
One of MacKenzie Scott's latest donations takes her HBCU giving to well over $1 billionplaceholder alt text
By Sydney LakeSeptember 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.